Literature DB >> 16500560

HFSA 2006 Comprehensive Heart Failure Practice Guideline.

.   

Abstract

Heart failure (HF) is a syndrome characterized by high mortality, frequent hospitalization, reduced quality of life, and a complex therapeutic regimen. Knowledge about HF is accumulating so rapidly that individual clinicians may be unable to readily and adequately synthesize new information into effective strategies of care for patients with this syndrome. Trial data, though valuable, often do not give direction for individual patient management. These characteristics make HF an ideal candidate for practice guidelines. The 2006 Heart Failure Society of America comprehensive practice guideline addresses the full range of evaluation, care, and management of patients with HF.

Entities:  

Mesh:

Year:  2006        PMID: 16500560     DOI: 10.1016/j.cardfail.2005.11.005

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  51 in total

1.  Isosorbide dinitrate and hydralazine as therapy for African Americans with heart failure; a failed paradigm?

Authors:  Clyde W Yancy; Arthur Feldman
Journal:  Clin Transl Sci       Date:  2009-08       Impact factor: 4.689

2.  A program of professional accreditation of hospital wards by the Italian Society of Internal Medicine (SIMI): self- versus peer-evaluation.

Authors:  Massimo Vanoli; Giancarlo Traisci; Alberto Franchini; Gianpiero Benetti; Pietro Serra; Maria Alice Monti
Journal:  Intern Emerg Med       Date:  2011-08-11       Impact factor: 3.397

Review 3.  Effects of supplementation with polyunsaturated fatty acids in patients with heart failure.

Authors:  Savina Nodari; Marco Triggiani; Alessandra Manerba; Giuseppe Milesi; Livio Dei Cas
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

Review 4.  Heart failure with preserved ejection fraction in the elderly: scope of the problem.

Authors:  Ken Kaila; Mark J Haykowsky; Richard B Thompson; D Ian Paterson
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

5.  Loss-of-function DNA sequence variant in the CLCNKA chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation.

Authors:  Thomas P Cappola; Scot J Matkovich; Wei Wang; Derek van Booven; Mingyao Li; Xuexia Wang; Liming Qu; Nancy K Sweitzer; James C Fang; Muredach P Reilly; Hakon Hakonarson; Jeanne M Nerbonne; Gerald W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-19       Impact factor: 11.205

6.  Comparison of medication practices in patients with heart failure and preserved versus those with reduced ejection fraction (from the Cardiovascular Research Network [CVRN]).

Authors:  Robert J Goldberg; Jerry H Gurwitz; Jane S Saczynski; Grace Hsu; David D McManus; David J Magid; David H Smith; Alan S Go
Journal:  Am J Cardiol       Date:  2013-02-01       Impact factor: 2.778

7.  Therapeutic implications of implantable device-based monitoring of patients with heart failure.

Authors:  Eric Popjes; John P Boehmer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-09

8.  Improvements in signs and symptoms during hospitalization for acute heart failure follow different patterns and depend on the measurement scales used: an international, prospective registry to evaluate the evolution of measures of disease severity in acute heart failure (MEASURE-AHF).

Authors:  Larry A Allen; Marco Metra; Olga Milo-Cotter; Gerasimos Filippatos; Leonardo H Reisin; Daniel R Bensimhon; Edoardo G Gronda; Paolo Colombo; G Michael Felker; Livio Dei Cas; Dimitrios T Kremastinos; Christopher M O'Connor; Gadi Cotter; Beth A Davison; Howard C Dittrich; Eric J Velazquez
Journal:  J Card Fail       Date:  2008-08-15       Impact factor: 5.712

Review 9.  Mechanisms of disease: detrimental adrenergic signaling in acute decompensated heart failure.

Authors:  David S Feldman; Terry S Elton; Benjamin Sun; Mickey M Martin; Mark T Ziolo
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-02-19

Review 10.  Management strategies for stage-D patients with acute heart failure.

Authors:  David Feldman; Doron M Menachemi; William T Abraham; Randell K Wexler
Journal:  Clin Cardiol       Date:  2008-07       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.